Literature DB >> 8943254

Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.

T Toida1, R E Hileman, A E Smith, P I Vlahova, R J Linhardt.   

Abstract

Two new oligosaccharides were prepared from heparin by its partial depolymerization using heparin lyase I (EC 4.2.2.7) in an attempt to prepare oligosaccharides having intact antithrombin III binding sites. The oligosaccharides were purified by chromatography on the basis of both size and charge and demonstrated a high level of purity by capillary electrophoresis. One- and two-dimensional 1H NMR spectroscopy at 500 MHz revealed the structure of each oligosaccharide. The octasaccharide and decasaccharide are DeltaUAp2S(1-->4)-alpha-DGlcNpS6S(1-->4)-alpha-L-IdoAp (1-->4)-alpha-D -GlcNpAc6S(1-->4)-betaD-GlcAp(1-->4)-alpha-D-GlcNpS 3S6S(1-->4)-alpha- L-IdoAp2S(1-->4)alpha-D-GlcNpS6S (where DeltaUAp is 4-deoxy-alpha-L-threo-hex-enopyranosyluronic acid, GlcNp is 2-amino-2-deoxy-glucopyranose, GlcAp is glucopyranosyluronic acid, S is sulfate and Ac is acetate) and DeltaUAp2S(1-->4)-alpha-D-GlcNpS6S(1-->4)-alpha-L-IdoAp++ +(1-->4)-alpha- D-GlcNpAc6S (1-->4)-beta-D-GlcAp(1-->4)-alpha-D-GlcNpS3S6S(1-->4)-alpha- L-IdoAp2S (1-->4)-alpha-D-GlcNpS6S(1-->4)-alpha-L-IdoAp2S(1-->4)-alpha -D-GlcNpS 6S, respectively. A hexasaccharide containing a similar structural motif to that found in the antithrombin III binding site and having greatly reduced anticoagulant activity was also isolated. The structure of the hexasaccharide is DeltaUAp2S(1-->4)-alpha-D-GlcNpAc6S(1-->4)-beta-D-GlcAp++ +(1-->4)-alpha- D-GlcNpS3S6S(1-->4)-alpha-L-IdoAp(1-->4)-alpha-D-GlcNpS6S . The octasaccharide and decasaccharide correspond to the predominant structural motif found in porcine intestinal mucosal heparin. Sufficient quantities of the decasaccharide were obtained to examine its interaction with antithrombin III using microtitration calorimetry. This decasaccharide bound to antithrombin III with similar avidity as heparin and showed comparable anticoagulant activity, as determined using an antithrombin III dependent anti-factor Xa assay. Interestingly, while both decasaccharide and heparin bound to antithrombin with nanomolar affinity, very little heat of binding was observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943254     DOI: 10.1074/jbc.271.50.32040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Heparin sequencing brings structure to the function of complex oligosaccharides.

Authors:  M A Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Determination of the primary structure and carboxyl pK (A)s of heparin-derived oligosaccharides by band-selective homonuclear-decoupled two-dimensional (1)H NMR.

Authors:  Khanh Nguyen; Dallas L Rabenstein
Journal:  Anal Bioanal Chem       Date:  2010-10-03       Impact factor: 4.142

3.  Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.

Authors:  Li Fu; Fuming Zhang; Guoyun Li; Akihiro Onishi; Ujjwal Bhaskar; Peilong Sun; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2014-03-14       Impact factor: 3.534

4.  Antithrombin-binding oligosaccharides: structural diversities in a unique function?

Authors:  Marco Guerrini; Pierre A J Mourier; Giangiacomo Torri; Christian Viskov
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

5.  Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.

Authors:  Z Shriver; M Sundaram; G Venkataraman; J Fareed; R Linhardt; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.

Authors:  Z Shriver; R Raman; G Venkataraman; K Drummond; J Turnbull; T Toida; R Linhardt; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis.

Authors:  Derek J Langeslay; Consuelo N Beecher; Annamaria Naggi; Marco Guerrini; Giangiacomo Torri; Cynthia K Larive
Journal:  Anal Chem       Date:  2012-12-31       Impact factor: 6.986

8.  Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue.

Authors:  Marco Guerrini; Sara Guglieri; Benito Casu; Giangiacomo Torri; Pierre Mourier; Christian Boudier; Christian Viskov
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

9.  Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties.

Authors:  Christian Viskov; Stefano Elli; Elena Urso; Davide Gaudesi; Pierre Mourier; Frederic Herman; Christian Boudier; Benito Casu; Giangiacomo Torri; Marco Guerrini
Journal:  J Biol Chem       Date:  2013-07-10       Impact factor: 5.157

10.  Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction.

Authors:  Heidi Barth; Eva K Schnober; Fuming Zhang; Robert J Linhardt; Erik Depla; Bertrand Boson; Francois-Loic Cosset; Arvind H Patel; Hubert E Blum; Thomas F Baumert
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.